other material
confidence high
sentiment neutral
materiality 0.40
Calidi Biotherapeutics raises $1.2M in registered direct offering of 1,025,640 shares
Calidi Biotherapeutics, Inc.
- 1,025,640 shares sold at $1.17/share; gross proceeds ~$1.2M.
- Offering closed Sept 21, 2026; no underwriter, placement agent, or discounts.
- Net proceeds for working capital and general corporate purposes.
- Directors and executive officers subject to 60-day lock-up; company agreed to 45-day equity standstill.
- Shares offered via effective Form S-3 shelf (File No. 333-282456).